{
  "id": 20282743,
  "title": "J&J to buy eye disease biotech Ollin Biosciences for up to $3.3B",
  "url": "https://urgent.news/2026/11/16/j-j-to-buy-eye-disease-biotech-ollin-biosciences-for-up-to-3-3b",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-16T13:52:04.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/jj-to-buy-eye-disease-biotech-ollin-biosciences-for-up-to-3-3b/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Johnson & Johnson said Monday it will snap up Ollin Biosciences in a deal worth up to $3.3 billion, just a little over a year after the ophthalmology biotech broke cover ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}